SCHEMBL1684840

SCHEMBL1684840

Cc1cn([C@]2(C)O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)nc1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 4/20 0.34
LMNA P02545 3/20 0.34
MTOR P42345 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 2/20 0.34
THRB P10828 1/20 0.34
MDM2 Q00987 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
POLB P06746 1/20 0.34
GMNN O75496 1/20 0.34
TP53 P04637 1/20 0.34
NFKB1 P19838 1/20 0.34
THPO P40225 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
BLM P54132 1/20 0.34
HBB P68871 1/20 0.34
PMP22 Q01453 1/20 0.34
PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6828970 0.89 DNMT1 (0.35) DNMT1LMNAMTORSMN1; SMN2ALDH1A1
SCHEMBL233463 0.88 DNMT1 (0.34) DNMT1LMNAMTORSMN1; SMN2ALDH1A1
SCHEMBL2550062 0.87 ALB (0.43) DNMT1LMNAMTORSMN1; SMN2ALDH1A1
SCHEMBL28922015 0.87 DNMT1 (0.34) DNMT1LMNAMTORSMN1; SMN2ALDH1A1
SCHEMBL234386 0.85 LMNA (0.34) DNMT1LMNAMTORSMN1; SMN2ALDH1A1
SCHEMBL29290642 0.85 LMNA (0.35) DNMT1LMNAMTORSMN1; SMN2ALDH1A1
SCHEMBL4428190 0.84 LMNA (0.34) DNMT1LMNAMTORSMN1; SMN2ALDH1A1
SCHEMBL17748439 0.83 LMNA (0.33) DNMT1LMNAMTORSMN1; SMN2ALDH1A1
SCHEMBL6241745 0.82 LMNA (0.35) DNMT1LMNAMTORSMN1; SMN2ALDH1A1
SCHEMBL20500065 0.82 LMNA (0.33) DNMT1LMNAMTORSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0813539-B1 IMPROVED PROCESS FOR THE SYNTHESIS OF 2'-O-SUBSTITUTED PYRIMIDINES AND OLIGOMERIC COMPOUNDS THEREFROM ISIS PHARMACEUTICALS INC (US) 2006-05-24 EP claimed
WO-2023131926-A2 MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION AUSPER BIOPHARMA CO., LTD. (CN) 2023-07-13 WO disclosed
EP-3997059-A1 CATIONIC LIPIDS AND USES THEREOF Factor Bioscience Inc. (US) 2022-05-18 EP disclosed
WO-2021003462-A1 CATIONIC LIPIDS AND USES THEREOF FACTOR BIOSCIENCE INC. (US) 2021-01-07 WO disclosed
WO-2011041311-A2 COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION FROM AND REJECTION OF BIOMATERIALS AND OTHER METHODS YALE UNIVERSITY (US) 2011-04-07 WO disclosed